- Search results for K05089
Cookie preferences
This website uses cookies, which are necessary for the technical operation of the website and are always set. Other cookies, which increase the comfort when using this website, are used for direct advertising or to facilitate interaction with other websites and social networks, are only set with your consent.
Configuration
Technically required
These cookies are necessary for the basic functions of the shop.
"Allow all cookies" cookie
"Decline all cookies" cookie
CSRF token
Cookie preferences
Currency change
Customer-specific caching
FACT-Finder tracking
Individual prices
Selected shop
Session
Comfort functions
These cookies are used to make the shopping experience even more appealing, for example for the recognition of the visitor.
Note
Show the facebook fanpage in the right blod sidebar
Statistics & Tracking
Affiliate program
Conversion and usertracking via Google Tag Manager
Track device being used
225 products were found matching "K05089"!
Close filters
Filter by:
No results were found for the filter!
Item number: TGM-T6479-100mg
Description: Dovitinib lactate hydrate (TKI258) is the Lactate of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and...
Keywords: | Dovitinib (TKI258) Lactate, Dovitinib Lactate, TKI258 |
Application: | Targets fms-related tyrosine kinase 3 [EC:2.7.10.1] (FLT3, FLK2, CD135) |
CAS | 915769-50-5 |
MW: | 482.51 D |
From 49.00€
*
Item number: TGM-T63505-100mg
Description: Tivozanib hydrochloride hydrate (AV-951 hydrochloride hydrate) is an orally active, selective, and potent vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor that inhibits VEGFR-1, VEGFR-2, and VEGFR-3. Target: VEGFR. Smiles:...
Keywords: | KRN951 hydrochloride hydrate, AV-951 hydrochloride hydrate |
Application: | Targets FMS-like tyrosine kinase 1 [EC:2.7.10.1] (FLT1, VEGFR1) |
CAS | 682745-41-1 |
MW: | 509.34 D |
From 54.00€
*
Item number: TGM-T6091-100mg
Description: CP-673451 is a specific inhibitor of PDGFRalpha/beta (IC50: 10/1 nM) with antiangiogenic and antitumor activity and the selectivity is higher 450-fold than other angiogenic receptors. Target: PDGFR, VEGFR, c-Kit. Smiles: COCCOc1ccc2n(cnc2c1)-c1ccc2cccc(N3CCC(N)CC3)c2n1. References: Roberts WG, et al....
Application: | PDGFRbeta inhibitor |
CAS | 343787-29-1 |
MW: | 417.5 D |
From 45.00€
*
Item number: TGM-T1448-50mg
Description: Dasatinib (BMS-354825) is an orally active, ATP-competitive tyrosine kinase inhibitor that targets Src and Bcr-Abl (Ki=16/30 pM), with antitumor activity, used in the treatment of leukemia and lymphoma. Target: c-Kit, Autophagy, Bcr-Abl, Apoptosis, Src. Smiles:...
Keywords: | BMS-354825 |
Application: | Targets abelson tyrosine-protein kinase 1 [EC:2.7.10.2] (ABL1) |
CAS | 302962-49-8 |
MW: | 488.01 D |
From 38.00€
*
Item number: TGM-T14137-100mg
Description: AG 1295, a selective inhibitor of platelet-derived growth factor receptor (PDGFR) tyrosine-kinase, effectively halts PDGFR autophosphorylation without impacting the autophosphorylation of the EGF receptor[1][2][3][4]. Target: PDGFR. Smiles: Cc1cc2ncc(nc2cc1C)-c1ccccc1. References: Kovalenko M, et al....
Application: | PDGF receptor kinase inhibitor |
CAS | 71897-07-9 |
MW: | 234.3 D |
From 46.00€
*
Item number: TGM-T17219-100mg
Description: Vatalanib is a VEGFR2/KDR inhibitor (IC50: 37 nM). Target: VEGFR. Smiles: ClC1=CC=C(NC2=NN=C(CC3=CC=NC=C3)C3=CC=CC=C23)C=C1
Application: | Targets platelet-derived growth factor receptor beta [EC:2.7.10.1] (PDGFRB, CD140B) |
CAS | 212141-54-3 |
MW: | 346.81 D |
From 42.00€
*
Item number: TGM-T15616-100mg
Description: JNJ- 10198409 is a relatively selective and ATP competitive PDGF-RTK inhibitor (IC50=2 nM). JNJ-10198409 has good activity against PDGFR-beta kinase (IC50=4.2 nM) and PDGFR-alpha kinase (IC50=45 nM). It is a dual-mechanism, antiangiogenic, and tumor cell antiproliferative agent. Target: PDGFR. Smiles:...
Keywords: | JNJ-10198409 |
Application: | PDGF-BB inhibitor |
CAS | 627518-40-5 |
MW: | 325.34 D |
From 30.00€
*
Item number: TGM-T1448L-100mg
Description: Dasatinib monohydrate (BMS-354825 Monohydrate) is an orally bioavailable synthetic small molecule-inhibitor of SRC-family protein-tyrosine kinases. Dasatinib monohydrate binds to and inhibits the growth-promoting activities of these kinases. Apparently, because of its less stringent binding affinity for...
Keywords: | BMS-354825 Monohydrate |
Application: | Targets abelson tyrosine-protein kinase 1 [EC:2.7.10.2] (ABL1) |
CAS | 863127-77-9 |
MW: | 506.03 D |
From 34.00€
*
Item number: TGM-T1667-100mg
Description: Tandutinib (CT53518) (MLN518, CT53518), an effective FLT3 antagonist (IC50: 0.22 µM), can also inhibit c-Kit and PDGFR, 15-20 fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR, and KDR. Target: c-Kit, CSF-1R, Src, FLT, PDGFR, Apoptosis....
Keywords: | NSC726292, CT53518, MLN518 |
Application: | Targets fms-related tyrosine kinase 3 [EC:2.7.10.1] (FLT3, FLK2, CD135) |
CAS | 387867-13-2 |
MW: | 562.7 D |
From 40.00€
*
Item number: TGM-T3476-100mg
Description: JI-101 (CGI-1842) is an oral multi-kinase inhibitor that targets vascular endothelial growth factor receptor type 2 (VEGFR-2), platelet derived growth factor receptor beta (PDGFR-beta), and ephrin type-B receptor 4 (EphB4). Target: VEGFR, PDGFR, Ephrin Receptor. Smiles:...
Keywords: | CGI-1842, JI 101 |
Application: | VEGFR2 inhibitor |
CAS | 900573-88-8 |
MW: | 466.33 D |
From 31.00€
*
Item number: TGM-T60624-200mg
Description: (E/Z)-AG490 ((E/Z)-Tyrphostin AG490) is a racemic compound comprising the isomers (E)-AG490 and (Z)-AG490. (E)-AG490 functions as a tyrosine kinase inhibitor, targeting EGFR, Stat-3, and JAK2/3. Target: Others. Smiles: C(=C(C(NCC1=CC=CC=C1)=O)C#N)C2=CC(O)=C(O)C=C2
Application: | PDGF receptor autophosphorylation inhibitor |
CAS | 134036-52-5 |
MW: | 294.3 D |
1,229.00€
*
Item number: TGM-T6184-100mg
Description: Orantinib (NSC 702827) , a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also highly inhibits Flk-1 and FGFR1 trans-phosphorylation. It shows little effect against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2 and does not suppresses EGFR. Target: Apoptosis, PDGFR, VEGFR, FGFR....
Keywords: | SU6668, NSC 702827, TSU-68 |
Application: | Tyrosine kinase inhibitor |
CAS | 252916-29-3 |
MW: | 310.35 D |
From 46.00€
*